American Journal of Medical Genetics Part C-Seminars in Medical Geneti

Papers
(The TQCC of American Journal of Medical Genetics Part C-Seminars in Medical Geneti is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic81
C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease61
Bone health in RASopathies53
Health care satisfaction and medical literacy habits among caregivers of individuals with Down syndrome40
Endocrinological manifestations in RASopathies38
Unlocking the potential of the UK 100,000 Genomes Project—lessons learned from analysis of the “Congenital Malformations caused by Ciliopathies” cohort37
Catatonia responsive to corticosteroids in a patient with an SCN2A variant32
Obstetrics and gynecology in Ehlers‐Danlos syndrome: A brief review and update30
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics30
Cover Image, Volume 187, Number 4, December 202129
A Genomic Analysis of Usher Syndrome: Population‐Scale Prevalence and Therapeutic Targets28
Down syndrome across the lifespan28
Research Review of Myhre Syndrome28
Evolution of Health Care in Turner Syndrome28
Table of Contents, Volume 196, Number 4, December 202425
Proximal urea cycle defects are challenging to detect with newborn screening: Results of a prospective pilot study using post‐analytical tools23
Everyone Is a Tomato: Metagnostic Narratives of Genetic Revelation21
Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals21
Central nervous system involvement in individuals withRASopathies21
20
Retrospective review of the code status of individuals with Down syndrome during the COVID‐19 era19
Co‐occurring conditions in Down syndrome: Findings from a clinical database19
Publication schedule for 202319
Fascial thickness and stiffness in hypermobile Ehlers‐Danlos syndrome18
Advances in assessment of hypermobility‐related disorders18
My Journey With Arthrogryposis and Some of the People Who Made a Difference17
Revisiting the Neuropsychological and Clinical Profile of Mosaic Turner Syndrome With a Ring X Chromosome16
16
Children with Down syndrome who experience developmental skill loss, characterization, and phenomenology: A case series15
Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade‐long experience14
Cover Image, Volume 190, Number 1, March 202214
Genetic testing and glomerular hematuria—A nephrologist's perspective14
Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype14
Caregivers' concerns and supports needed to care for adults with Down syndrome14
Adult experiences in Beckwith–Wiedemann syndrome13
Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care13
Non‐Invasive Prenatal Testing by Cell‐Free DNA (cfNIPT) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes12
Occurrence of mosaic Down syndrome and prevalence of co‐occurring conditions in Medicaid enrolled adults, 2016–201912
Correction to “Experiences With Offering Pro Bono Medical Genetics Services in the West Indies: Benefits to Patients, Physicians, and the Community”12
Family Lore, a Variant of Uncertain Significance, and CADASIL12
Initial description and evaluation of EDS ECHO: An international effort to improve care for people with the Ehlers‐Danlos syndromes and hypermobility spectrum disorders11
Whole‐genome sequencing holds the key to the success of gene‐targeted therapies11
A plot TWIST11
In Utero Therapies, the Next Frontier11
Normal joint range of motion in children with Down syndrome11
Table of Contents, Volume 199, Number 1, March 202510
Cover Image, Volume 196, Number 1, March 202410
Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM110
Cover Image, Volume 190, Number 3, September 202210
Disease mechanisms of monogenic congenital anomalies of the kidney and urinary tract10
Table of Contents, Volume 190, Number 2, June 202210
Cover Image, Volume 193, Number 1, March 20239
Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re‐classification of an ARID1B missense variant8
Parental Decision‐Making Following a Prenatal Diagnosis of Turner Syndrome: A Systematic Review8
Table of Contents, Volume 193, Number 4, December 20238
Data sharing to advance gene‐targeted therapies in rare diseases8
Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies8
Ophthalmologic and neuro‐ophthalmologic findings in children with Down syndrome8
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease8
New prospectives on treatment opportunities in RASopathies7
Circles7
Genesis and genetics of a miracle7
Table of Contents, Volume 193, Number 1, March 20237
Ode to Fiona: The Face of Fortitude in FBXL4 Deficiency7
Publication schedule for 20217
Treatment of PDGFRB‐Related Penttinen Syndrome With Imatinib in a Young Child7
0.78211307525635